Compositions and methods for nucleic acid sequencing
US-11236387-B2 · Feb 1, 2022 · US
US11859244B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11859244-B2 |
| Application number | US-202318185786-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 17, 2023 |
| Priority date | Sep 3, 2021 |
| Publication date | Jan 2, 2024 |
| Grant date | Jan 2, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.
Opening claim text (preview).
What is claimed is: 1. A kit comprising a first oligonucleotide comprising a first sequencing primer sequence and a second sequencing primer binding sequence; a second oligonucleotide comprising from 5′ to 3′, a first platform primer sequence and a sequence complementary to the first sequencing primer sequence; a third oligonucleotide comprising from 5′ to 3′, a second platform primer sequence and a sequence complementary to the second sequencing primer binding sequence; wherein said first platform primer sequence comprises SEQ ID NO:92; and said second platform primer sequence comprises SEQ ID NO:89. 2. The kit of claim 1 , wherein the first sequencing primer sequence is SEQ ID NO:152. 3. The kit of claim 2 , wherein the second sequencing primer binding sequence is SEQ ID NO:178. 4. The kit of claim 1 , further comprising a solid support. 5. The kit of claim 4 , wherein said solid support is a flow cell, particle, chip, slide, multi-well container, or unpatterned solid support. 6. The kit of claim 4 , wherein said solid support is a multi-well container. 7. The kit of claim 4 , wherein said solid support further comprises two or more wells, wherein each well comprises a first plurality of immobilized oligonucleotides, wherein each oligonucleotide of the first plurality comprises the first platform primer sequence, and a second plurality of immobilized oligonucleotides, wherein each oligonucleotide of the second plurality comprises the second platform primer sequence. 8. The kit of claim 7 , wherein said solid support comprises about 0.2 wells to about 4.0 wells per μm 2 . 9. The kit of claim 7 , wherein each of the wells is separated from each of the other wells by about 0.2 μm to about 2.0 μm. 10. The kit of claim 1 , further comprising a sequencing polymerase, and one or more amplification polymerases. 11. The kit of claim 10 , further comprising a plurality of native deoxynucleotides (dNTPs) and a plurality of modified dNTPs. 12. The kit of claim 11 , wherein said plurality of modified dNTPs comprises a reversible terminator moiety. 13. The kit of claim 1 , wherein said second oligonucleotide, said third oligonucleotide, or both said second and third oligonucleotides further comprise an index sequence. 14. The kit of claim 13 , wherein said index sequence comprises between 8 to 12 nucleotides. 15. The kit of claim 1 , further comprising a polynucleotide adapter, said polynucleotide adapter comprising a first strand comprising a first binding sequence and a first tail sequence; and a second strand comprising a second binding sequence and a second tail sequence, wherein at least a portion of the first binding sequence is hybridized to a portion of the second binding sequence; wherein the first tail sequence comprises SEQ ID NO:5, SEQ ID NO:9, SEQ ID NO:85, SEQ ID NO:92, SEQ ID NO:90, SEQ ID NO:88, SEQ ID NO:117, SEQ ID NO:119, SEQ ID NO:121, or SEQ ID NO:123 and the second tail sequence comprises SEQ ID NO:4, SEQ ID NO:102, SEQ ID NO:104, SEQ ID NO:106, SEQ ID NO:108, SEQ ID NO:134, SEQ ID NO:136, SEQ ID NO:138, or SEQ ID NO:140, and the first binding sequence comprises SEQ ID NO:152 and the second binding sequence comprises SEQ ID NO:178. 16. The kit of claim 15 , wherein the polynucleotide adapter is a Y polynucleotide adapter. 17. The kit of claim 15 , wherein the polynucleotide adapter is a hairpin adapter. 18. The kit of claim 17 , wherein the hairpin adapter comprises a cleavable site. 19. The kit of claim 17 , wherein the first tail sequence is covalently attached to the second tail sequence. 20. A kit comprising: a first oligonucleotide comprising from 5′ to 3′, a first platform primer sequence and a first sequencing primer sequence; a second oligonucleotide comprising from 5′ to 3′, a second platform primer sequence and a second sequencing primer sequence; wherein said first platform primer sequence comprises SEQ ID NO:92; and said second platform primer sequence comprises SEQ ID NO:89. 21. The kit of claim 20 , wherein the first sequencing primer sequence is SEQ ID NO:152.
Ligating adaptors · CPC title
involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title
using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title
characterised by the manufacture of the container or its components · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.